Bisphosphonate-Associated Osteonecrosis of the Jaw

This issue provides an update on important factors to consider when assessing bisphosphonate-associated osteonecrosis of the jaw and clarifies questions and concerns regrading this class of drugs. Incorporates 13 illustrations.